Jiyong Wu Selected Research

Jiyong Wu Research Topics

3	Neoplasms (Cancer) 07/2023 - 03/2022
1	Rhabdomyolysis 03/2024
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2024
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2023
1	Lymphoid Leukemia 12/2023
1	Squamous Cell Carcinoma of Head and Neck 01/2023
1	Anemia 01/2023
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2023
1	Neoplasm Metastasis (Metastasis) 03/2022
1	Gram-Negative Bacterial Infections 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Soft Tissue Infections 01/2022
1	Hemorrhage 01/2022
1	Mycoses (Diseases, Fungus) 01/2022

2	PlatinumIBA 01/2024 - 01/2022
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 03/2024
1	Monoclonal AntibodiesIBA 01/2024
1	Programmed Cell Death 1 ReceptorIBA 01/2024
1	pembrolizumabIBA 01/2024
1	Agammaglobulinaemia Tyrosine KinaseIBA 12/2023
1	Bendamustine Hydrochloride FDA Link 12/2023
1	Rituximab (Mabthera)FDA Link 12/2023
1	zanubrutinibIBA 12/2023
1	TubulinIBA 07/2023
1	veratric acidIBA 01/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2023
1	IronIBA 01/2023
1	Histone Deacetylase InhibitorsIBA 01/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2022
1	Cisplatin (Platino)FDA LinkGeneric 03/2022
1	bendazacIBA 03/2022
1	ProdrugsIBA 03/2022
1	Tigecycline (Tygacil)FDA Link 01/2022
1	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	niraparibIBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	olaparibIBA 01/2022
1	Isocitrate LyaseIBA 01/2022
1	BilirubinIBA 01/2022